Lactobacillus plantarum P 17630


Prevention of vaginal infections, restoring the healthy vaginal microflora. In case of acute vaginal infection, used as a maintenance treatment, after a medical therapy. Topical treatment of vaginal infections such as vaginitis and vaginosis, including vulvovaginal candidiasis. Restoration of vaginal microflora during antibiotic or chemotherapy treatments.

Deposited at the Laboratorium voor Microbiologie BCCM (Gent, Belgium). Deposit N°LMG P 17630

Isolated from healthy human environment.

Also available as Active Pharmaceutical Product (API)

The microbial strain is not genetically modified and it is of natural origin (OMG Reg. (CE) 1829/2003 e 1830/2003)

Shelf life raw material: 12 months when stored below 8°C.

Scientific reference(s)

Adherence of Lactobacillus plantarum P 17630 in soft-gel capsule formulation versus Doderlein’s bacillus in tablet formulation to vaginal epithelial cells (Bonetti et al.)

L’adesione del Lactobacillus plantarum P 17630 alle cellule vaginali inibisce l’adesività della Candida albicans (Culici, et al.)

Vaginal capsules of Lactobacillus plantarum P17630 for prevention of relapse of candida vulvovaginitis: an Italian multicentre observation study (Carriero et al.)

Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study (De Seta et al.)

Microbiological Characteristics of Lactobacillus Plantarum P17630 contained in vaginal suppositories (Dho G. et al.)

Observational prospective study on Lactobacillus plantarum P17630 in the prevention of vaginal infections, during and after systemic antibiotic therapy or in women with recurrent vaginal or genitourinary infections (Cianci et al,)

Vaginal adhesion of Lactobacillus plantarum P17630 after probiotic food supplement oral administration: a preliminary in vivo study (Montella et al.)

Evaluation of the action of Lactobacillus plantarum P17630, orally administrated, on vaginal microflora and definition of the suitable treatment (Montella et al.)

New evidence on oral L. plantarum P17630 product in women with history of recurrent vulvovaginal candidiasis (RVVC): a randomized double-blind placebo-controlled study (Vladareanu et al.)

Additional info

Therapeutical area(s)

Women health


Vaginal candidiasis



Lactobacillus plantarum P 17630 is available at

Scroll to Top
Browse companies by type
Brought to you by